ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma.

Cancer Biology & Therapy
J Spencer LilesAndrey Frolov

Abstract

Historically, ErbB3 has been overlooked within the ErbB receptor family due to its perceived lack of tyrosine kinase activity. We have previously demonstrated that in pancreatic cancer ErbB3 is the preferred dimerization partner of EGFR, ErbB3 protein expression level directly correlates with the anti-proliferative effect of erlotinib (an EGFR-specific tyrosine kinase inhibitor), and transient knockdown of ErbB3 expression results in acquired resistance to EGFR-targeted therapy. In this study, we develop a stable isogenic model of ErbB3 expression in an attempt to decipher ErbB3's true contribution to pancreatic cancer tumorigenesis and to examine how this receptor affects cellular sensitivity to EGFR-targeted therapy. Analysis of the EGFR-ErbB3 heterodimer demonstrates that ligand-induced PI3K-AKT signaling is limited to ErbB3-expressing cells and that this signaling cascade can be partially abrogated by inhibiting EGFR function with erlotinib. Using our model of exogenous ErbB3 expression we showed a direct relationship between ErbB3 protein levels and increased pancreatic cancer cell proliferation in vitro. In vivo, ErbB3(+)PANC-1 xenografts had a significantly larger tumor volume than PANC-1 control xenografts (ErbB3-PANC-1...Continue Reading

References

Nov 1, 1992·The Journal of Pathology·N R LemoineG Klöppel
Jul 25, 1998·The Biochemical Journal·N J HellyerJ G Koland
Apr 6, 2000·The Journal of Endocrinology·M R KritzikN Sarvetnick
Mar 17, 2001·Nature Reviews. Molecular Cell Biology·Y Yarden, M X Sliwkowski
Jul 11, 2003·Proceedings of the National Academy of Sciences of the United States of America·Thomas HolbroNancy E Hynes
Jul 1, 2004·FEBS Letters·Mitchell B BergerMark A Lemmon
Feb 26, 2005·Proceedings of the National Academy of Sciences of the United States of America·Jeffrey A EngelmanLewis C Cantley
Jul 11, 2006·Nature Reviews. Molecular Cell Biology·Ami Citri, Yosef Yarden
Nov 11, 2006·International Journal of Cancer. Journal International Du Cancer·Armin KolbHelmut Friess
Apr 25, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Malcolm J MooreUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Apr 26, 2007·Cancer Biology & Therapy·Andrey FrolovJ Pablo Arnoletti
Nov 21, 2007·Cancer Investigation·Chris Papageorgio, Michael C Perry
Apr 10, 2008·International Journal of Cancer. Journal International Du Cancer·Yoko UenoIkuo Saiki
Apr 12, 2008·Cancer Gene Therapy·G Sithanandam, L M Anderson
May 29, 2009·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Jun 17, 2009·International Journal of Cancer. Journal International Du Cancer·Marta SolerTimothy M Thomson

❮ Previous
Next ❯

Citations

Mar 23, 2012·Carcinogenesis·Malgorzata Magdalena SakInger Helene Madshus
Dec 1, 2012·Chemotherapy Research and Practice·Ning JiangZhuo Georgia Chen
Aug 31, 2013·PLoS Computational Biology·Harish ShankaranHaluk Resat
Nov 28, 2012·World Journal of Gastroenterology : WJG·Falko LangeRobert Jaster
Jan 23, 2014·Acta Biochimica Et Biophysica Sinica·Youngseok LeeBolin Liu
May 24, 2013·Carcinogenesis·Malgorzata Magdalena SakEspen Stang
Dec 1, 2015·Expert Opinion on Biological Therapy·Do-Youn Oh, Yung-Jue Bang
Jun 20, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Chen GongChunhua Wan
Mar 10, 2011·International Journal of Cancer. Journal International Du Cancer·Gunamani SithanandamLucy M Anderson
Jun 3, 2014·Molecular Cancer·Jian MaBolin Liu
Aug 9, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Mirza MasroorAlpana Saxena
Sep 9, 2015·BioMed Research International·Carolina TorresSonia Perales
Aug 3, 2010·Cancer Biology & Therapy·Ralf Landgraf
Jun 5, 2016·Molecular & Cellular Proteomics : MCP·Emily S HumphreyRoger J Daly
Mar 19, 2019·International Journal of Cancer. Journal International Du Cancer·Laura BourillonThierry Chardès
Jan 17, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Nobuaki HirotaJames G Martin
Jul 31, 2018·Oncology Reviews·Rosalin MishraJoan T Garrett
Feb 23, 2020·International Journal of Molecular Sciences·Sara S RinneAnzhelika Vorobyeva
Sep 29, 2020·Expert Review of Anticancer Therapy·Umbreen HafeezAndrew M Scott
Dec 7, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Abdelhamid BejiAxel Ullrich
Mar 20, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Adam J CamblinAlexey A Lugovskoy
Jul 29, 2019·The American Journal of Pathology·Laurel E BlackSteven L Carroll
Mar 18, 2021·Advanced Biology·Xiaoxiao LiuYuexiang Wang
Jul 2, 2021·Acta Crystallographica. Section F, Structural Biology Communications·Filip RadomAndreas Plückthun
Jul 30, 2021·Pathology Oncology Research : POR·Shui LiuXuewen Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Related Papers

Journal of the National Cancer Institute
Alberto OcanaEitan Amir
Chemotherapy Research and Practice
Ning JiangZhuo Georgia Chen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Markus ReschkeAxel Ullrich
© 2021 Meta ULC. All rights reserved